The Claim
Oral administration of liposomal vitamin C (Lipomac™) in healthy adults results in a peak plasma concentration of 16,462.86 ng/mL and an area under the curve of 122,809 ng·h/L, which is 2.36 times higher than the peak plasma concentration of 6,950 ng/mL and area under the curve of 60,506 ng·h/L observed with nonliposomal vitamin C.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When taken orally, liposomal vitamin C (Lipomac™) reaches 2.36 times higher levels in the blood than regular vitamin C, based on measurements of peak concentration and total exposure over time.
See the scientific wording
Liposomal vitamin C (Lipomac™) achieves a peak plasma concentration of 16,462.86 ng/mL and an area under the curve of 122,809 ng·h/L after oral administration in healthy adults, which is approximately 2.36 times higher than nonliposomal vitamin C (Cmax: 6,950 ng/mL; AUC: 60,506 ng·h/L), indicating significantly greater systemic exposure.
Vitamin C is wrapped in tiny fat bubbles that protect it from being broken down in the stomach and gut. These fat bubbles stick to the cells lining the intestine and get pulled inside, releasing vitamin C directly into the cells. From there, vitamin C moves into the bloodstream in much larger amounts than when it's taken without the fat coating.
What the research says
1 studyThis study found that when people take vitamin C in a special fatty bubble form (liposomal), their bodies absorb about 2.36 times more of it than when they take regular vitamin C pills. That means more vitamin C gets into the bloodstream.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.